Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 公共衛生學院
  3. 公共衛生碩士學位學程
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/99914
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor董鈺琪zh_TW
dc.contributor.advisorYu-Chi Tungen
dc.contributor.author周筱妘zh_TW
dc.contributor.authorHsiao-Yun Chouen
dc.date.accessioned2025-09-19T16:17:00Z-
dc.date.available2025-09-20-
dc.date.copyright2025-09-19-
dc.date.issued2025-
dc.date.submitted2025-08-01-
dc.identifier.citation1.Sacco, R.L., et al., The Heart of 25 by 25: Achieving the Goal of Reducing Global and Regional Premature Deaths From Cardiovascular Diseases and Stroke. Circulation, 2016. 133(23): p. e674-e690.
2.World Health Organization. The top 10 causes of death. 2023 [cited 2023; Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death.
3.Martin, S.S., et al., 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation, 2025. 151(8): p. e41-e660.
4.衛生福利部統計處. 111年國人死因統計結果. 2023 [cited 2023/12/3; Available from: https://www.mohw.gov.tw/cp-16-74869-1.html.
5.Evaluation, I.f.H.M.a. GBD Compare. 2025 4/4]; Available from: https://vizhub.healthdata.org/gbd-compare/.
6.衛生福利部中央健康保險署. 重要統計資料. 2023 2023/12]; Available from: https://www.nhi.gov.tw/Content_List.aspx?n=D529CAC4D8F8E77B&topn=23C660CAACAA159D.
7.衛生福利部統計處. 全民健康保險醫療統計. 2023 2023/12]; Available from: https://dep.mohw.gov.tw/dos/lp-5103-113-xCat-y110.html.
8.Christianson, J.B., S. Leatherman, and K. Sutherland, Lessons from evaluations of purchaser pay-for-performance programs: a review of the evidence. Med Care Res Rev, 2008. 65(6 Suppl): p. 5s-35s.
9.Organization for Economic Cooperation and Development, O. Hospital performance. 2023 [cited 2023 2023/12]; Available from: https://www.oecd.org/health/hospital-performance.htm.
10.衛生福利部中央健康保險署. 急診品質提升方案. 2023 2023/12]; Available from: https://www.nhi.gov.tw/Content_List.aspx?n=609FD07ABEB1FB86&topn=5FE8C9FEAE863B46.
11.吳季軒, 探討急診論質計酬對於介入性心導管治療費用與結果之影響, in 健康政策與管理研究所. 2016, 國立臺灣大學. p. 1-92.
12.Mathes, T., et al., Pay for performance for hospitals. Cochrane Database of Systematic Reviews, 2019(7).
13.行政院衛生署全民健康保險醫療品質委員會, 二代健保論質計酬. 醫療品質雜誌, 2007. 1(1): p. 54-56.
14.陳宗泰, 鍾國彪, and 賴美淑, 另一種流行趨勢-論成效計酬的趨勢與展望. 台灣公共衛生雜誌, 2007. 26(5): p. 353-370.
15.McClure, W., Competition and the pursuit of quality: a conversation with Walter McClure. Interview by John K. Iglehart. Health affairs (Project Hope), 1988. 7(1): p. 79-90.
16.Baker, A., Crossing the Quality Chasm: A New Health System for the 21st Century. BMJ, 2001. 323(7322): p. 1192.
17.Kahn, C.N., 3rd, et al., Snapshot of hospital quality reporting and pay-for-performance under Medicare. Health Aff (Millwood), 2006. 25(1): p. 148-62.
18.Millenson, M.L. and J. Macri, Will the Affordable Care Act move patient-centeredness to center stage. Urban Institute Policy Brief, 2012: p. 1-10.
19.Kanwal, A., et al., What drives general practitioners in the UK to improve the quality of care? A systematic literature review. BMJ Open Quality, 2021. 10(1): p. e001127.
20.Roland, M., Linking physicians' pay to the quality of care--a major experiment in the United kingdom. N Engl J Med, 2004. 351(14): p. 1448-54.
21.Association, A.M. Pay-for-Performance Principles and Guidelines H-450.947. 2022 [cited 2024 2023/1/6]; Available from: https://policysearch.ama-assn.org/policyfinder/detail/Pay-for-Performance%20Principles%20and%20Guidelines%20H-450.947?uri=%2FAMADoc%2FHOD.xml-0-4071.xml.
22.OECD/WHO, Paying for Performance in Health Care: Implications for Health System Performance and Accountability. 2014, Open University Press-McGraw-Hill: Buckingham.
23.莊智鈞, 林青青, and 鄭守夏, 簡介價值基礎的健康照護及其對台灣的啟示. 台灣公共衛生雜誌, 2022. 41(6): p. 575-589.
24.Donabedian, A., Explorations in quality assessment and monitoring. Volume II : the criteria and standarts of quality; Explorations en évaluation et surveillance de la qualité. Volume II. Critères et mesures de la qualité. 1982: Health Administration Press, Ann Arbor.
25.鍾國彪 and 游宗憲, 醫療品質指標發展的挑戰與展望:我們還能做什麼?. 臺灣公共衛生雜誌, 2009. 28(5): p. 345-360.
26.林世崇, 呂炎原, and 徐漢仲, 心肌梗塞之重新定義與臨床分類. 內科學誌, 2013. 24(1): p. 1-11.
27.Thygesen, K., et al., Third universal definition of myocardial infarction. European Heart Journal, 2012. 33(20): p. 2551-2567.
28.Thygesen, K., et al., Fourth Universal Definition of Myocardial Infarction (2018). Circulation, 2018. 138(20): p. e618-e651.
29.Mechanic, O.J., M. Gavin, and S.A. Grossman, Acute Myocardial Infarction, in StatPearls. 2023, StatPearls Publishing
Copyright © 2023, StatPearls Publishing LLC.: Treasure Island (FL).
30.陳明豐, 冠狀動脈心臟病-心肌梗塞. 健康世界, 1989(158): p. 27-29.
31.Killip, T. and J.T. Kimball, Treatment of myocardial infarction in a coronary care unit: A Two year experience with 250 patients. The American Journal of Cardiology, 1967. 20(4): p. 457-464.
32.許曉溱, 死亡率風險校正模型之建立與驗證-以急性心肌梗塞為例, in 健康政策與管理研究所. 2012, 國立臺灣大學. p. 1-126.
33.Tsao, C.W., et al., Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association. Circulation, 2022. 145(8): p. e153-e639.
34.Roth, G.A., et al., Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. Journal of the American College of Cardiology, 2017. 70(1): p. 1-25.
35.Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet, 2016. 388(10053): p. 1545-1602.
36.Salari, N., et al., The global prevalence of myocardial infarction: a systematic review and meta-analysis. BMC Cardiovascular Disorders, 2023. 23(1): p. 206.
37.Yeh, R.W., et al., Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med, 2010. 362(23): p. 2155-65.
38.Ibanez, B., et al., 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J, 2018. 39(2): p. 119-177.
39.Evaluation, I.f.H.M.a.
GBD Compare. [cited 2024/2; Available from: https://www.thelancet.com/lancet/visualisations/gbd-compare.
40.Yin, W.H., et al., The temporal trends of incidence, treatment, and in-hospital mortality of acute myocardial infarction over 15years in a Taiwanese population. Int J Cardiol, 2016. 209: p. 103-13.
41.Lee, C.H., et al., Patterns of Acute Myocardial Infarction in Taiwan from 2009 to 2015. Am J Cardiol, 2018. 122(12): p. 1996-2004.
42.Lloyd-Jones, D.M., et al., Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation, 2006. 113(6): p. 791-8.
43.Expert Panel on Detection, E. and T.o.H.B.C.i. Adults, Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA, 2001. 285(19): p. 2486-2497.
44.Vaduganathan, M., et al., The Global Burden of Cardiovascular Diseases and Risk. Journal of the American College of Cardiology, 2022. 80(25): p. 2361-2371.
45.Purdy, S., et al., Emergency admissions for coronary heart disease: A cross-sectional study of general practice, population and hospital factors in England. Public Health, 2011. 125(1): p. 46-54.
46.Li, Y.H., et al., 2020 Focused Update of the 2012 Guidelines of the Taiwan Society of Cardiology for the Management of ST-Segment Elevation Myocardial Infarction. Acta Cardiol Sin, 2020. 36(4): p. 285-307.
47.Li, Y.-H., et al., 2018 Guidelines of the Taiwan Society of Cardiology, Taiwan Society of Emergency Medicine and Taiwan Society of Cardiovascular Interventions for the management of non ST-segment elevation acute coronary syndrome. Journal of the Formosan Medical Association, 2018. 117(9): p. 766-790.
48.陳永平, et al., 心肌梗塞之藥物治療新進展. 內科學誌, 2017. 28(3): p. 148-159.
49.Lu, L., et al., Myocardial Infarction: Symptoms and Treatments. Cell Biochemistry and Biophysics, 2015. 72(3): p. 865-867.
50.Members, A.T.F., et al., ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). European Heart Journal, 2012. 33(20): p. 2569-2619.
51.Kwiecinski, J., et al., Bypass Grafting and Native Coronary Artery Disease Activity. JACC: Cardiovascular Imaging, 2022. 15(5): p. 875-887.
52.蔡劭謙 and 王志鴻, 心肌血管重建治療的發展及現今臨床實務. 內科學誌, 2018. 29(1): p. 8-14.
53.Weintraub, W.S., et al., Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association. Circulation, 2011. 124(8): p. 967-90.
54.De Luca, L., et al., Modalities of treatment and 30-day outcomes of unselected patients older than 75 years with acute ST-elevation myocardial infarction: data from the BLITZ study. Journal of Cardiovascular Medicine, 2008. 9(10): p. 1045-1051.
55.Mantovani, L.G., et al., Burden of acute myocardial infarction. International Journal of Cardiology, 2011. 150(1): p. 111-112.
56.Services, C.f.M.M. Premier Hospital Quality Incentive Demonstration. 2023 [cited 2024 2023/1/7]; Available from: https://www.cms.gov/medicare/quality/initiatives/hospital-quality-initiative/premier-quality-incentive-demonstration.
57.財團法人醫院評鑑暨醫療品質策進會. 疾病照護品質認證. 2025; Available from: https://www.jct.org.tw/np-55-1.html.
58.Solomon, D.H. and S.E. Gabriel, Moving forward with quality: pay for reporting meets rheumatology. Arthritis Rheum, 2007. 57(5): p. 703-4.
59.Mellor, J., M. Daly, and M. Smith, Does It Pay to Penalize Hospitals for Excess Readmissions? Intended and Unintended Consequences of Medicare's Hospital Readmissions Reductions Program. Health Econ, 2017. 26(8): p. 1037-1051.
60.Izón, G.M. and C.A. Pardini, Association Between Medicare’s Mandatory Hospital Value-Based Purchasing Program and Cost Inefficiency. Applied Health Economics and Health Policy, 2018. 16(1): p. 79-90.
61.CMS. The Hospital Value-Based Purchasing (VBP) Program. 2024 [cited 2024 3/5]; Available from: https://www.cms.gov/medicare/quality/value-based-programs/hospital-purchasing.
62.Mason, T., Y.-S. Lau, and M. Sutton, Is the distribution of care quality provided under pay-for-performance equitable? Evidence from the Advancing Quality programme in England. International Journal for Equity in Health, 2016. 15(1): p. 156.
63.Sutton, M., et al., Reduced mortality with hospital pay for performance in England. N Engl J Med, 2012. 367(19): p. 1821-8.
64.Ikemura, N., et al., Consequence of reimbursement policy alteration for urgent PCI in Japan. The Lancet, 2018. 391(10136): p. 2208-2209.
65.厚生勞動省. 2014年診療醫療費用修訂. [cited March,30,2025; Available from: https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000032996.html.
66.衛生福利部中央健康保險署. 醫療給付改善方案專區. 2024 [cited 2024 2024/1/6]; Available from: https://www.nhi.gov.tw/Content_List.aspx?n=EBDEAEDEC639490C&topn=5FE8C9FEAE863B46.
67.Ryan, A.M., Effects of the Premier Hospital Quality Incentive Demonstration on Medicare patient mortality and cost. Health Serv Res, 2009. 44(3): p. 821-42.
68.Kruse, G.B., et al., The impact of hospital pay-for-performance on hospital and Medicare costs. Health Serv Res, 2012. 47(6): p. 2118-36.
69.Jha, A.K., et al., The long-term effect of premier pay for performance on patient outcomes. N Engl J Med, 2012. 366(17): p. 1606-15.
70.Banerjee, S., et al., Association between degree of exposure to the Hospital Value Based Purchasing Program and 30-day mortality: experience from the first four years of Medicare’s pay-for-performance program. BMC Health Services Research, 2019. 19(1): p. 921.
71.Glickman, S.W., et al., Pay for performance, quality of care, and outcomes in acute myocardial infarction. Jama, 2007. 297(21): p. 2373-80.
72.Sana, M.K., et al., Impact of Hospital Readmissions Reduction Program Policy on 30-Day and 90-Day Readmissions in Patients With Acute Myocardial Infarction: A 10-Year Trend From the National Readmissions Database. Current Problems in Cardiology, 2023. 48(7): p. 101696.
73.Deyo, R.A., D.C. Cherkin, and M.A. Ciol, Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol, 1992. 45(6): p. 613-9.
74.Quan, H., et al., Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care, 2005. 43(11): p. 1130-9.
75.Wagner, A.K., et al., Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther, 2002. 27(4): p. 299-309.
76.Hardin, J.W., & Hilbe, J.M, Generalized Estimating Equations. 2013: Chapman and Hall/CRC.
77.Tsao, C.W., et al., Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation, 2022. 145(8): p. e153-e639.
78.Krumholz, H.M., et al., Readmission After Hospitalization for Congestive Heart Failure Among Medicare Beneficiaries. Archives of Internal Medicine, 1997. 157(1): p. 99-104.
79.Chiu, I.M., et al., Relation of Socioeconomic Status to 1-Year Readmission and Mortality in Patients With Acute Myocardial Infarction. Am J Cardiol, 2022. 175: p. 19-25.
-
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/99914-
dc.description.abstract研究背景:為加強急重症之醫療照護,衛生福利部中央健康保險署自2012年5月起實施全民健康保險急診品質提升方案,期透過財務誘因以提升急性心肌梗塞照護品質,該方案自2019年2月起調升急性心肌梗塞照護獎勵由2,000點至6,000點。台灣僅有一篇研究探討急診品質提升方案介入之成效,且結論發現對於急診急性心肌梗塞接受介入性心導管(percutaneous coronary intervention, PCI)治療病人醫療費用及照護結果於研究期間影響可能沒有影響。
研究目的:本研究評估提升急診品質提升方案照護獎勵調升後,對於急性心肌梗塞病人接受介入性心導管照護過程、醫療費用及照護結果影響。
研究方法:本研究使用全民健康保險研究資料庫,選取2016年至2023年資料,主診斷為急性心肌梗塞病人,控制人口特質、醫療機構特質及時間趨勢,利用分段廣義估計方程式(Segmented Generalized estimating equation, GEE)羅吉斯迴歸模式,探討新品質提升方案之照護獎勵調升,對於病人30天內全因死亡、住院死亡及到院90分鐘內接受PCI治療之影響,並以線性模式探討整體醫療費用之影響。
研究結果:全民健康保險急診品質提升方案之急性心肌梗塞照護獎勵提升,對於急診急性心肌梗塞且接受介入性心導管治療之病人住院期間醫療費用、到院90分鐘內接受PCI治療、30天全因死亡及住院死亡均無影響。
結論:提升全民健康保險急診品質提升方案之急性心肌梗塞照護獎勵誘因,對於急診急性心肌梗塞且接受介入性心導管治療病人之照護過程、醫療費用及照護結果可能沒有影響。
zh_TW
dc.description.abstractBackground: To strengthen the quality of care for acute and critical illnesses, the National Health Insurance Administration (NHIA) of the Ministry of Health and Welfare in Taiwan launched the Emergency Department Pay-for-Performance Program (P4P) in May 2012. This initiative aimed to improve the quality of care for acute myocardial infarction (AMI) patients through financial incentives. In February 2019, the reward for AMI care was increased from 2,000 to 6,000 points.
To date, only one study in Taiwan has evaluated the impact of the Emergency P4P, with findings suggesting that the program may not have significantly affected medical costs or care outcomes for AMI patients undergoing percutaneous coronary intervention (PCI) during the study period.
Objective: This study aims to evaluate the impact of the Emergency P4P on the care processes, medical cost, and outcomes for AMI patients, with a specific focus on the effect of enhanced incentives on patients undergoing PCI.
Methods: This study utilized data from the National Health Insurance Research Database (NHIRD), covering the period from 2016 to 2023 for patients primarily diagnosed with acute myocardial infarction. A segmented generalized estimating equation (GEE) model was employed, adjusting for patient demographics, hospital characteristics, and time trends, to evaluate the impact of P4P reward adjustments and subsequent trends on patient outcomes. Specifically, the analysis focused on 30-day all-cause mortality, in-hospital mortality, and the probability of receiving PCI within 90 minutes of arrival using logistic regression, while a linear model was applied to assess the impact on overall medical costs.
Results: The enhancement of reward incentives under the Emergency Department P4P Program for acute myocardial infarction care was not significantly associated with differences in in-hospital medical costs, the likelihood of receiving PCI within 90 minutes of arrival, 30-day all-cause mortality, or in-hospital mortality among AMI patients undergoing PCI.
Conclusion: Increasing the reward incentives under the Emergency P4P for AMI care may not significantly influence the care processes, outcomes, or medical costs for AMI patients undergoing PCI.
The findings suggest that the impact of the P4P on the quality of care, outcomes, and medical costs for these patients may be limited.
en
dc.description.provenanceSubmitted by admin ntu (admin@lib.ntu.edu.tw) on 2025-09-19T16:17:00Z
No. of bitstreams: 0
en
dc.description.provenanceMade available in DSpace on 2025-09-19T16:17:00Z (GMT). No. of bitstreams: 0en
dc.description.tableofcontents口試委員會審定書 I
誌謝 II
中文摘要 III
英文摘要 IV
目次 VI
圖次 VIII
表次 IX
第一章 緒論 1
第一節 研究背景與動機 1
第二節 研究目的 3
第三節 實習單位簡介 4
第二章 文獻探討 5
第一節 論質計酬介紹 5
第二節 急性心肌梗塞介紹 8
第三節 急性心肌梗塞相關論質計酬介紹 14
第四節 相關實證研究 17
第五節 綜合評論 25
第三章 研究方法 26
第一節 研究設計與架構 26
第二節 研究假說 27
第三節 研究對象 28
第四節 資料來源與資料處理流程 29
第五節 研究變項操作型定義 32
第六節 統計分析方法 35
第四章 研究結果 37
第一節 描述性統計 37
第二節 雙變項分析 46
第三節 多變項分析 61
第五章 討論 68
第一節 研究方法 68
第二節 研究結果 70
第三節 研究限制 74
第六章 結論與建議 75
第一節 結論 75
第二節 建議 76
參考文獻 77
-
dc.language.isozh_TW-
dc.subject急性心肌梗塞zh_TW
dc.subject論質計酬zh_TW
dc.subject照護結果zh_TW
dc.subject照護過程zh_TW
dc.subject醫療費用zh_TW
dc.subjectPay-for-Performanceen
dc.subjectCare Outcomesen
dc.subjectAcute Myocardial Infarctionen
dc.subjectMedical Costsen
dc.title新論質計酬方案對於急性心肌梗塞接受介入性心導管治療之照護過程及照護結果影響zh_TW
dc.titleImpact of New Pay-for-Performance Program on Processes and Outcomes for Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Interventionen
dc.typeThesis-
dc.date.schoolyear113-2-
dc.description.degree碩士-
dc.contributor.oralexamcommittee鄭守夏;賴超倫zh_TW
dc.contributor.oralexamcommitteeShou-Hsia Cheng;Chao-Lun Laien
dc.subject.keyword急性心肌梗塞,論質計酬,照護結果,照護過程,醫療費用,zh_TW
dc.subject.keywordAcute Myocardial Infarction,Pay-for-Performance,Care Outcomes,Medical Costs,en
dc.relation.page86-
dc.identifier.doi10.6342/NTU202502082-
dc.rights.note同意授權(限校園內公開)-
dc.date.accepted2025-08-04-
dc.contributor.author-college公共衛生學院-
dc.contributor.author-dept公共衛生碩士學位學程-
dc.date.embargo-lift2030-07-01-
顯示於系所單位:公共衛生碩士學位學程

文件中的檔案:
檔案 大小格式 
ntu-113-2.pdf
  未授權公開取用
5.25 MBAdobe PDF檢視/開啟
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved